13FPulse
中
NU

NUTX NUTEX HEALTH INC

2026Q2 · CUSIP 67079U306 · Sector: Other

Piling in

Net holder growth ranks near the top of the market

Funds that own it
150
Institutions that reported holding it to the SEC
Net increase in holders
+24
Last quarter 126 → now 150
How unusual is that
Top 20%
Stronger buying than 86% of US stocks
What the filings say, in one paragraph

150 funds held NUTX at the end of 2026Q2, up 24 from the quarter before. That is stronger buying than 86.1% of US stocks — among the most piled-into names this quarter. On the business itself, revenue over the last 12 months was $847M(YoY +6.9%), the P/E is 7.4x, return on equity is 45.6%. NUTX has had 2 buying rushes in its history, and the price moved +13.3% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Other sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2024Q3: holders=29 2024Q4: holders=39 2025Q1: holders=44 2025Q2: holders=99 2025Q3: holders=95 2025Q4: holders=116 2026Q1: holders=126 2026Q2: holders=150 -55 -27.5 +0 +27.5 +55 2692158 24Q324Q425Q125Q225Q325Q426Q126Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 2 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 20% — —
2025Q2 Top 5% +13.4% +13.3%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
93
Change in large funds
+18
Total value they hold
$491M
Funds buying for the first time
41
Funds that sold out entirely
17
Price change that quarter
+54.0%
Funds holding puts (bearish)
0
Funds holding calls (bullish)
0

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
7.4
EPS (TTM)
$26.00
EPS YoY
+165.9%
Revenue (TTM)
$0.8B
Revenue YoY
+6.9%
Net margin
21.3%
ROE
45.6%
Debt ratio
47.4%
FCF (TTM)
$274M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2023-09-30: EPS -1.25 2023-12-31: EPS -7.47 2024-03-31: EPS -0.08 2024-06-30: EPS -0.07 2024-09-30: EPS -1.72 2024-12-31: EPS 11.12 2025-03-31: EPS 3.33 2025-06-30: EPS -2.95 2025-09-30: EPS 7.76 2025-12-31: EPS 2.34 2026-03-31: EPS 6.52 2026-06-30: EPS 9.38 0M 134M 268M $M -8.22 2.01 12.23 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
5 10 14 202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-24M38M99M 20162017201820192020202120222023202420252026
Latest quarter $74M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.